Onco

Bengaluru, India Founded: 2016 • Age: 10 yrs Minicorn Acquired By Apollo Hospitals
Comprehensive cancer care navigation and support services are provided.

About Onco

Onco is a Healthcare company based in Bengaluru (India) founded in 2016, and was acquired by Apollo Hospitals in July 2025. Comprehensive cancer care navigation and support services are provided. It operates on a On-Demand Services and Aggregator Model model. Onco has raised $12.98 million across 5 funding rounds from investors including Apollo Hospitals, Accel and Wellfound. The company has 24 employees. Onco was last valued at $46.55 million in April 2022. Its website onco.com draws about 15 thousand monthly visits. Its Indian entity Netdox Health Private Limited reported revenue of β‚Ή4.17 Cr. Onco offers products and services including Cancer Treatment Guidance, Diagnostic Test Booking, and Medicine Delivery. Its focus areas include Oncology and Cancer Care Services. Its competitors include Comprehensive Blood & Cancer Center, Sunrise Oncology Centre and Cancer Rounds; 1 of its 3 listed competitors has raised funding.

Company details

Onco is established as a comprehensive care partner in the cancer treatment journey. Services are provided across India, including consultation with expert oncologists, diagnostic test bookings, and medicine delivery. Support is offered through treatment planning, monitoring, and supportive care. Partnerships are maintained with over 23 treatment centers nationwide. Advanced oncology care and cutting-edge treatments are facilitated for patients at various stages of cancer.

  • Headquarters Bengaluru, India
  • Employees 24
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website onco.com
  • Social LinkedIn X Facebook
  • Acquired by Apollo Hospitals (Jul 2025)
  • Legal Name Apollo Hospitals Enterprise Ltd
  • Date of Incorporation 05 Jul, 2017
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹4.17 Cr

    FY 2024 · -28% YoY

  • Net Loss
    -₹3.34 Cr

    FY 2024 · -80% margin

  • EBITDA
    -₹3.09 Cr

    FY 2024 · -74% margin

  • Total Equity Funding
    $12.98M (USD)

    in 5 rounds

  • Latest Funding Round
    $1.72M (USD), Series A

    Apr 2022

  • Investors
  • Employee Count
    24
  • Acquired by

Products & Services of Onco

Onco offers a comprehensive portfolio of products and services, including Cancer Treatment Guidance, Diagnostic Test Booking, and Medicine Delivery.

Cancer Treatment Guidance
Healthcare Services

Guidance for cancer treatment is provided by experts.

Diagnostic Test Booking
Healthcare Services

Booking of diagnostic tests is facilitated at centers.

Medicine Delivery
Healthcare Services

Cancer medicines are delivered across India at discounts.

Funding Insights of Onco

Onco has successfully raised a total of $12.98M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $1.72 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12.98M
  • Total Rounds 5
  • Last Round Series A β€” $1.72M
  • First Round $1.33M

    (Aug 2017)

  • Investors Count 48

All 5 funding rounds of Onco with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2022$1.72MSeries A$46.55MRainmatter
Nov 2021$1.55MSeries A$46.18MAccel
Aug 2020$1.32MSeries A–Alteria Capital
–
Apr 2019$7.07MSeries A$β€’β€’β€’β€’β€’Accel
Aug 2017$1.33MSeed$β€’β€’β€’β€’β€’Accel
Valuation history
DateValuationStage
Apr 2022$46.55Mβ€’β€’β€’β€’β€’β€’β€’β€’
Nov 2021$46.18Mβ€’β€’β€’β€’β€’β€’β€’β€’
Apr 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Aug 2017$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Onco

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $46.55M (Apr 2022). 49 investors in total: 15 institutional and 34 angel.

Investors in Onco

Onco has secured backing from 49 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Apollo Hospitals, Accel and Wellfound.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Indian fund focused on fintech, health, and climate initiatives.
rainmatter.comBengaluru, India
Investments in tech startups are managed by AMEA Ventures.
ameaventures.tcc.modeLagos, Nigeria
Single family office of Arun Sarin
sarinfamilyindia.tcc.mode
Accel is recognized as a leading venture capital firm.
1983accel.comPalo Alto, United States
Venture capital firm focused on multiple sectors
sajidrahmanangelfund.tcc.modeSeattle, United States
Venture capital funding is provided to innovative startups in India.
qedinnovationlabs.tcc.modeMumbai, India
Venture capital firm focused on multiple sectors
ssinghtrust.tcc.modeRedwood City, United States
Angel Network for Bengaluru based companies
2015capierinvestments.comBengaluru, India
Dream Incubator is engaged in strategic consulting and business incubation.
2000dreamincubator.co.jpChiyoda City, Japan
Venture debt funding and structured finance for innovative startups in India.
2018alteriacapital.comMumbai, India
Premium access

Investor details for Onco

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Netdox Health Private Limited (Onco)

Netdox Health Private Limited is the primary company behind Onco. The board of Netdox Health Private Limited currently have 2 directors; the longest-serving is Amit Kumar Jotwani, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Amit Kumar Jotwani
DIN 07846666
Director05 Jul 20179 yrs 3 moNetdox Health Private Limited
Rashie Jain
DIN 07846651
Director05 Jul 20179 yrs 3 moNetdox Health Private Limited

Financials of Onco

Figures of Netdox Health Private Limited, the primary company behind Onco, for FY 2024. Revenue was ₹4.17 Cr (-28% year on year). Net loss was -₹3.34 Cr (-80% margin). EBITDA was -₹3.09 Cr (-74% margin). Revenue has grown at a compounded annual rate of +26% over three years and +41% over five years.

  • ₹4.17 CrRevenue · FY 2024 · -28% YoY
  • -₹3.34 CrNet loss · -80% margin
  • -₹3.09 CrEBITDA · -74% margin
  • ₹12.9 LakhPaid-up capital
  • 24Employees (provident fund records)
  • +26%Revenue CAGR, 3 years
  • +41%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Netdox Health Private Limited are on its company page.

Premium access

Detailed financial statements for Onco

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Onco

5 dated milestones of Onco across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Onco is founded.
  2. Funding First funding round of $1.3M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series A, of $1.7M.
  5. Exit Acquired by Apollo Hospitals.

Competitors of Onco

Onco has 3 listed competitors in our database, 1 of them funded. They include Comprehensive Blood & Cancer Center, Sunrise Oncology Centre and Cancer Rounds.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cbccusa.in1984Gandhinagar, India$6M78
Oncology services are delivered via a chain of specialized centers.
sunriseoncocare.com2015Mumbai, India44
Operates a chain of oncology clinics offering specialized cancer care services.
cancerrounds.com2019Gurugram, India
Offers expert consultations, treatments, and information for cancer patients in India.
Premium access

Detailed competitors of Onco

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Onco

The website of Onco (onco.com) receives about 14.7K visits a month.

  • Monthly visits
    14.7K

    ▲ 183.9% vs previous month

Similar websites

Websites whose visitors overlap most with Onco. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
urologists.org
urologists.org
100%
#4,733,737–
targetingcancer.com.au
targetingcancer.com.au
95%
#2,407,966–
cancer.net
cancer.net
85%
#6,320,954–
treatcancer.com
treatcancer.com
79%
#623,770–
eortc.be
eortc.be
77%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 21 similar websites and full traffic analytics for Onco

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Onco (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 230.8 MUSD 328.97 M5,212
Online platform offering multiple healthcare services
2013Bengaluru, Karnataka, IndiaUSD 199.22 MUSD 62.4 M52
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Onco

Premium access

Complete news archive for Onco

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about Onco on our blog

Frequently Asked Questions about Onco

Onco was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Onco is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Onco is a funded company, having raised a total of $12.98M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.33M, raised on Aug 2017.

Onco has 24 employees.

The primary company behind Onco, Netdox Health Private Limited, reported revenue of β‚Ή4.17 Cr for FY 2024, down 28% year on year.

Onco is established as a comprehensive care partner in the cancer treatment journey. Services are provided across India, including consultation with expert oncologists, diagnostic test bookings, and medicine delivery. Support is offered through treatment planning, monitoring, and supportive care. Partnerships are maintained with over 23 treatment centers nationwide. Advanced oncology care and cutting-edge treatments are facilitated for patients at various stages of cancer.

Onco offers Cancer Treatment Guidance, Diagnostic Test Booking, and Medicine Delivery.

Onco has 49 investors. Key investors include Apollo Hospitals, Accel, Wellfound, Alteria Capital, and Dream Incubator.

The valuation of Onco is $46.55M as of Apr 2022.

Onco operates through Netdox Health Private Limited.

Yes. Onco was acquired by Apollo Hospitals in July 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available